Facebook
Twitter
LinkedIn
ForwardPulse - A-B-CMV is NOT Easy as 1-2-3 in Pediatrics: Pediatric Considerations for Cytomegalovirus (CMV) Management in Hematopoietic Stem
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Pediatric Considerations for Cytomegalovirus (CMV) Management in Hematopoietic Stem Cell Transplant Patients
Target Audience
Pharmacist
Learning Objectives
1. Identify pathophysiology and diagnostics for cytomegalovirus (CMV) infection in hematopoietic stem cell transplant
(HCT) patients.
2. Discuss recommendations for CMV prophylaxis, with a focus on differences between pediatric and adult HCT
patients.
3. Describe treatment options for CMV in HCT, including refractory or resistant cases.
Additional Information
| Attachment | Size |
|---|---|
 Tamulonis_ Audience Disclosure Slides.pptx | 48.31 KB |
 1-25-22 Pulse.docx | 16.18 KB |
| Tamulonis_ Abstract Handout Outline.docx | 41.78 KB |
| Tamulonis _ PULSE_CMV Treatment and Prophylaxis in HCT_FINAL.pptx | 564.94 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Pediatric Considerations for Cytomegalovirus (CMV) Management in Hematopoietic Stem Cell Transplant Patients
Erin Tamulonis, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.